Description
Lidamitol Pharmacodynamics
Tolperisone hydrochloride is a central myorelaxant. The exact mechanism of action is unknown. As a result of membrane-stabilizing action, it prevents the conduction of excitation in the primary afferent fibers, blocking mono- and polysynaptic reflexes of the spinal cord. A likely secondary mechanism of action is to block transmitter release by blocking the entry of calcium ions into synapses.
Reduces reflex readiness in the reticulospinal pathways of the brainstem.
Increases peripheral blood flow. This effect is not related to the effect of the drug on the central nervous system and may be due to the weak antispasmodic and antiadrenergic effect of tolperizone.
Lidocaine hydrochloride has local anesthetic effect and has no systemic action when dosed by Lidamy Gol according to the instructions.
Indications
– Symptomatic treatment of spasticity in adults due to stroke.
– Treatment of painful muscle spasm associated with diseases of the musculoskeletal system (spondylosis, spondyloarthrosis, cervical and lumbar syndromes).
Contraindications
Hypersensitivity to any of the components of the drug (including lidocaine), severe myasthenia gravis, children under 18 years of age, pregnancy, lactation (due to lack of data).
Caution:
Caution should be exercised in patients with renal and hepatic impairment. Dosage adjustment is not required.
Pregnancy and lactation:
The drug is contraindicated in pregnancy and during breast-feeding (due to lack of data).
Dosage and administration administration
- Adults: 1 ml 2 times a day intramuscularly or 1 ml once a day intravenously.
- Procedure of the polymer ampoule:
1. Take the ampoule and shake it by holding the neck. 2.
2. Rotate and separate the valve from the ampoule. 3.
3. immediately connect the syringe luer to the ampoule through the hole formed.
4. Draw the contents of the ampoule into the syringe.
5. Slide the needle onto the syringe.
